Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation

Author： Stöllberger Claudia   Finsterer Josef  

Publisher： MDPI

E-ISSN： 1424-8247|5|2|155-168

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.5, Iss.2, 2012-02, pp. : 155-168

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines

By Armaganijan Luciana   Patel Dimpi   Dietrich Cristiano   Morillo Carlos A.  

Pharmaceuticals, Vol. 5, Iss. 4, 2012-04 ,pp. : 384-397

MDPI

Access to resources Recommend Favorite

Newer Anticoagulants for Non-Valvular Atrial Fibrillation

By Harburger Joseph M.   Aronow Wilbert S.  

Pharmaceuticals, Vol. 5, Iss. 5, 2012-05 ,pp. : 469-480

MDPI

Access to resources Recommend Favorite

The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation

By Christou Georgios A.   Christou Konstantinos A.   Korantzopoulos Panagiotis   Rizos Evangelos C.   Nikas Dimitrios N.   Goudevenos John A.  

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 22870-22887

MDPI

Access to resources Recommend Favorite

Looking into a Conceptual Framework of ROS–miRNA–Atrial Fibrillation

By Lee Seahyoung   Choi Eunhyun   Cha Min-Ji   Hwang Ki-Chul  

International Journal of Molecular Sciences, Vol. 15, Iss. 12, 2014-11 ,pp. : 21754-21776

MDPI

Access to resources Recommend Favorite

Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice

By Ferreira João Pedro   Santos Mário  

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-01 ,pp. : 3133-3147

MDPI

Access to resources Recommend Favorite